Moseley Ken
Sr. VP and General Counsel at BELLICUM PHARMACEUTICALS, INC
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jul 13, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BELLICUM PHARMACEUTICALS, INCSr. VP and General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualJul 1, 2015 2015
Sold 15,000 shares at $20.62 ($309k)
Moseley Ken, Sr. VP and General Counsel
Sold 99.4% of holdings ($311k position)97 shares leftFirst sale on recordFiling
- 2 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualNov 2, 2015 +124 days
Sold 15,000 shares at $13.00 ($195k)
Moseley Ken, Sr. VP and General Counsel
Sold 99.4% of holdings ($196k position)97 shares leftFiling
- 3 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualJun 2, 2016 +213 days
Sold 15,000 shares at $13.00 ($195k)
Moseley Ken, Sr. VP and General Counsel
Sold 98.7% of holdings ($198k position)196 shares leftFiling
- 4 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualAug 15, 2016 +74 days
Sold 1,000 shares at $20.00 ($20k)
Moseley Ken, Sr. VP and General Counsel
Sold 74.4% of holdings ($27k position)344 shares left0.1x usual sizeFiling
- 5 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualSep 20, 2016 +36 days
Sold 2,200 shares at $20.01 ($44k)
Moseley Ken, Sr. VP and General Counsel
Sold 86.5% of holdings ($51k position)344 shares left0.1x usual sizeFiling
- 6 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualSep 23, 2016 +3 days
Sold 11,800 shares at $20.10 ($237k)
Moseley Ken, Sr. VP and General Counsel
Sold 97.2% of holdings ($244k position)344 shares left0.8x usual sizeFiling
- 7 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualJul 13, 2017 +293 days
Sold 13,823 shares at $12.26 ($169k)
Moseley Ken, Sr. VP and General Counsel
Sold 96.6% of holdings ($175k position)491 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2017 | Jul 17, 2017 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 13,823 | $169k | 96.6% | Unusual | SEC |
| Sep 23, 2016 | Sep 23, 2016 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 11,800 | $237k | 97.2% | Unusual | SEC |
| Sep 20, 2016 | Sep 20, 2016 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 2,200 | $44k | 86.5% | Unusual | SEC |
| Aug 15, 2016 | Aug 17, 2016 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 1,000 | $20k | 74.4% | Unusual | SEC |
| Jun 2, 2016 | Jun 6, 2016 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 15,000 | $195k | 98.7% | Unusual | SEC |
| Nov 2, 2015 | Nov 4, 2015 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 15,000 | $195k | 99.4% | Unusual | SEC |
| Jul 1, 2015 | Jul 6, 2015 | BELLICUM PHARMACEUTICALS, INC | Sr. VP and General Counsel | Form 4 sale | 15,000 | $309k | 99.4% | Unusual | SEC |